Literature DB >> 19657575

Pus swabs in incision and drainage of perianal abscesses: what is the point?

Edmund Leung1, Kirsten McArdle, Marcelino Yazbek-Hanna.   

Abstract

BACKGROUND: The clinical effectiveness of pus swabs for microbiological analysis during incision and drainage of perianal abscess is controversial. Its cost implication is often overlooked. The present study aimed to determine if submission of pus swabs can be avoided without a negative effect on outcome.
METHODS: All consecutive cases of incision and drainage of perianal abscess between January 2004 and 2008 were retrospectively reviewed. Patient demographics, microbiological results, and clinical outcome with a follow-up of 6 months were assessed.
RESULTS: A review of patient records revealed 235 cases (59 F:176 M; age range: 6-99 years; median: 37 years). In 38 cases no swabs were taken; in 28 cases (12%), 106 cases (45%), and 16 cases (7%) swabs contained skin flora organisms, coliform/Bacteroides, and sterile, respectively. Within 6 months follow-up, 185 of the abscesses had healed, leaving 39 cases of fistula (25 cases had setons remained in situ for their fistulas at 6 months follow-up) and 11 patients were lost from follow-up. Fistulas were not associated with coliform/Bacteroides found on microbiological analysis (P > 0.05). In only 4 cases (1.7%) were the swab results mentioned in follow-up reports.
CONCLUSIONS: Surgeons tend not to review microbiological results at patient follow-up. Furthermore, the preliminary findings suggest that microbiological results have no correlation with presence of fistulas or prognosis. Randomized controlled trials are warranted to assess whether abandoning submission of pus swabs will affect clinical effectiveness of treatment in patients with perianal abscess.

Entities:  

Mesh:

Year:  2009        PMID: 19657575     DOI: 10.1007/s00268-009-0190-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  5 in total

1.  A classification of fistula-in-ano.

Authors:  A G Parks; P H Gordon; J D Hardcastle
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

Review 2.  The management of acute anorectal sepsis.

Authors:  R H Grace
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

3.  The aerobic and anaerobic bacteriology of perirectal abscesses.

Authors:  I Brook; E H Frazier
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Not documented--not done.

Authors:  M Mandell
Journal:  Nursing       Date:  1994-08

5.  The relevance of microbiology in the management of anorectal sepsis.

Authors:  S J Eykyn; R H Grace
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

  5 in total
  5 in total

1.  Perianal abscess and fistula-in-ano in children: clinical characteristic, management and outcome.

Authors:  Cağatay Evrim Afşarlar; Ayşe Karaman; Gönül Tanır; Ibrahim Karaman; Engin Yılmaz; Derya Erdoğan; Haşim Ata Maden; Yusuf Hakan Cavuşoğlu; Ismet Faruk Ozgüner
Journal:  Pediatr Surg Int       Date:  2011-10       Impact factor: 1.827

2.  Auditing the Routine Microbiological Examination of Pus Swabs From Uncomplicated Perianal Abscesses: Clinical Necessity or Old Habit?

Authors:  Lida Lalou; Lucy Archer; Paul Lim; Leo Kretzmer; Ali Mohammed Elhassan; Afolabi Awodiya; Charalampos Seretis
Journal:  Gastroenterology Res       Date:  2020-06-18

3.  An unusual cause of perianal fistula.

Authors:  L Kocierz; E Leung; V Thumbe
Journal:  J Surg Case Rep       Date:  2011-10-01

4.  Drug resistant bacteria in perianal abscesses are frequent and relevant.

Authors:  Fabienne Bender; Lukas Eckerth; Moritz Fritzenwanker; Juliane Liese; Ingolf Askevold; Can Imirzalioglu; Winfried Padberg; Andreas Hecker; Martin Reichert
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

5.  Does Anti-TNF-α Therapy Affect the Bacteriological Profile of Specimens Collected from Perianal Lesions? A Retrospective Analysis in Patients with Crohn's Disease.

Authors:  Jolanta Gruszecka; Rafał Filip
Journal:  Int J Environ Res Public Health       Date:  2022-03-02       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.